Anavex Life Sciences Corp (AVXL)

[McMagyar]

look two things: the Data is going to be REVOLUTIONARY! A3-71 Getting Orphan Status means FDA believes Anavex has First in Class Drug for CNS Diseases. PERIOD.
Second: Todd Cambpell of Motley Fool said this in 2011:
###Alzheimer's disease is so tough to treat, it's hard not to be excited about ANY drug that shows promise in trials, even if those trials happen to be very early stage. And it doesn't get much earlier-stage than Biogen's BIIB-037, a drug that was most recently in phase 1 trials designed to establish safety, not efficacy.####
The CAPS are MINE:
Stop whining about Data release..it is so OFF THE CHARTS UNBELIEVABLE.
They are Preparing for RESPONSE..Positive and Negative..SO GET OVER IT.